Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Clinical Genitourinary Cancer
|
December 3, 2014
African-american race is a predictor of seminal vesicle invasion after radical prostatectomy
Kosj Yamoah, Amy Walker, Elaine Spangler, et al.
International Journal of Oncology
|
June 14, 2013
Ectopic expression of the TERE1 (UBIAD1) protein inhibits growth of renal clear cell carcinoma cells: altered metabolic phenotype associated with reactive oxygen species, nitric oxide and SXR target genes involved in cholesterol and lipid metabolism
William J Fredericks, Hankun Yin, Priti Lal, et al.
Molecular Cancer Research : MCR
|
April 4, 2025
VAV2 drives EGFR-mediated Rac1 responses in prostate cancer
Martin J Baker, Suli Zhang, Daniel Zhang, et al.
The Journal of Urology
|
January 20, 2022
Does Perioperative Testosterone Predict Post-Prostatectomy Genomic Risk Score?
Mohammed Shahait, Joseph G Cheaib, Elai Davicioni, et al.
The American Journal of Pathology
|
December 26, 2003
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
Jeff Holzbeierlein, Priti Lal, Eva LaTulippe, et al.
Oncogene
|
May 17, 2018
COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
Rachana Garg, Jorge M Blando, Carlos J Perez, et al.
Nature
|
July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells
Andrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Transplantation Direct
|
November 2, 2020
Circulating Donor Heart Exosome Profiling Enables Noninvasive Detection of Antibody-mediated Rejection
Robert W Hu, Laxminarayana Korutla, Sanjana Reddy, et al.
JAMA Oncology
|
December 4, 2015
Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development
Amy S Clark, Thomas B Karasic, Angela DeMichele, et al.
Nature Medicine
|
May 6, 2014
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T Motz, Stephen P Santoro, Li-Ping Wang, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Clinical Genitourinary Cancer
|
December 3, 2014
African-american race is a predictor of seminal vesicle invasion after radical prostatectomy
Kosj Yamoah, Amy Walker, Elaine Spangler, et al.
International Journal of Oncology
|
June 14, 2013
Ectopic expression of the TERE1 (UBIAD1) protein inhibits growth of renal clear cell carcinoma cells: altered metabolic phenotype associated with reactive oxygen species, nitric oxide and SXR target genes involved in cholesterol and lipid metabolism
William J Fredericks, Hankun Yin, Priti Lal, et al.
Molecular Cancer Research : MCR
|
April 4, 2025
VAV2 drives EGFR-mediated Rac1 responses in prostate cancer
Martin J Baker, Suli Zhang, Daniel Zhang, et al.
The Journal of Urology
|
January 20, 2022
Does Perioperative Testosterone Predict Post-Prostatectomy Genomic Risk Score?
Mohammed Shahait, Joseph G Cheaib, Elai Davicioni, et al.
The American Journal of Pathology
|
December 26, 2003
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
Jeff Holzbeierlein, Priti Lal, Eva LaTulippe, et al.
Oncogene
|
May 17, 2018
COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
Rachana Garg, Jorge M Blando, Carlos J Perez, et al.
Nature
|
July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells
Andrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Transplantation Direct
|
November 2, 2020
Circulating Donor Heart Exosome Profiling Enables Noninvasive Detection of Antibody-mediated Rejection
Robert W Hu, Laxminarayana Korutla, Sanjana Reddy, et al.
JAMA Oncology
|
December 4, 2015
Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development
Amy S Clark, Thomas B Karasic, Angela DeMichele, et al.
Nature Medicine
|
May 6, 2014
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T Motz, Stephen P Santoro, Li-Ping Wang, et al.
Page
of 12